Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain
- PMID: 17907800
- PMCID: PMC1994969
- DOI: 10.1371/journal.ppat.0030113
Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain
Conflict of interest statement
Figures


Similar articles
-
Structural and functional analysis of botulinum neurotoxin subunits for pH-dependent membrane channel formation and translocation.Biochim Biophys Acta. 2015 Oct;1854(10 Pt A):1510-6. doi: 10.1016/j.bbapap.2015.05.013. Epub 2015 May 23. Biochim Biophys Acta. 2015. PMID: 26012869 Free PMC article.
-
The light chain of botulinum neurotoxin forms channels in a lipid membrane.Biochem Biophys Res Commun. 1994 Nov 30;205(1):751-7. doi: 10.1006/bbrc.1994.2729. Biochem Biophys Res Commun. 1994. PMID: 7999108
-
Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B.Nat Struct Biol. 2000 Aug;7(8):693-9. doi: 10.1038/78005. Nat Struct Biol. 2000. PMID: 10932256
-
[Function and subunit structure of botulinum toxin].Tanpakushitsu Kakusan Koso. 2006 Dec;51(15):2334-40. Tanpakushitsu Kakusan Koso. 2006. PMID: 17154059 Review. Japanese. No abstract available.
-
[Structure and function of botulinum toxin].Hokkaido Igaku Zasshi. 1995 Jan;70(1):19-28. Hokkaido Igaku Zasshi. 1995. PMID: 7744367 Review. Japanese.
Cited by
-
Glycine insertion at protease cleavage site of SNAP25 resists cleavage but enhances affinity for botulinum neurotoxin serotype A.Protein Sci. 2012 Mar;21(3):318-26. doi: 10.1002/pro.2017. Protein Sci. 2012. PMID: 22170566 Free PMC article.
-
DNA vaccines targeting heavy chain C-terminal fragments of Clostridium botulinum neurotoxin serotypes A, B, and E induce potent humoral and cellular immunity and provide protection from lethal toxin challenge.Hum Vaccin Immunother. 2015;11(8):1961-71. doi: 10.1080/21645515.2015.1066051. Hum Vaccin Immunother. 2015. PMID: 26158319 Free PMC article.
-
Paclitaxel is an inhibitor and its boron dipyrromethene derivative is a fluorescent recognition agent for botulinum neurotoxin subtype A.J Med Chem. 2013 Apr 11;56(7):2791-803. doi: 10.1021/jm301829h. Epub 2013 Mar 29. J Med Chem. 2013. PMID: 23484537 Free PMC article.
-
Probing the properties of PTEN specific botulinum toxin type E mutants.J Neural Transm (Vienna). 2025 Jan 23. doi: 10.1007/s00702-025-02879-2. Online ahead of print. J Neural Transm (Vienna). 2025. PMID: 39849213
-
Recombinant derivatives of botulinum neurotoxin A engineered for trafficking studies and neuronal delivery.Protein Expr Purif. 2010 May;71(1):62-73. doi: 10.1016/j.pep.2009.12.013. Epub 2010 Jan 4. Protein Expr Purif. 2010. PMID: 20045734 Free PMC article.
References
-
- Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, et al. Botulinum toxin as a biological weapon: Medical and public health management. JAMA. 2001;285:1059–1070. - PubMed
-
- Schiavo G, Matteoli M, Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol Rev. 2000;80:717–766. - PubMed
-
- Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol. 1998;5:898–902. - PubMed
-
- Lacy DB, Stevens RC. Sequence homology and structural analysis of the clostridial neurotoxins. J Mol Biol. 1999;291:1091–1104. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources